These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24092374)

  • 1. Beyond the standard of care: the role of cytopathology in molecular testing of cancer.
    Kulesza P
    Cancer Treat Res; 2014; 160():273-82. PubMed ID: 24092374
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug resistance in cancer - searching for mechanisms, markers and therapeutic agents.
    O'Connor R; Clynes M; Dowling P; O'Donovan N; O'Driscoll L
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):805-17. PubMed ID: 18028026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HSP90 inhibitors for cancer therapy and overcoming drug resistance.
    Jhaveri K; Modi S
    Adv Pharmacol; 2012; 65():471-517. PubMed ID: 22959035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical implication of tumor marker expressions suggesting biological characters of malignancies].
    Ariyoshi Y; Kuwabara M
    Nihon Rinsho; 1996 Jun; 54(6):1568-73. PubMed ID: 8691610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The search for optimal response prediction in cancer leads to a personalized approach.
    Van Cutsem E; Ciardiello F
    Target Oncol; 2010 Mar; 5(1):3-4. PubMed ID: 20349283
    [No Abstract]   [Full Text] [Related]  

  • 6. Loss-of-function genetic screens as a tool to improve the diagnosis and treatment of cancer.
    Mullenders J; Bernards R
    Oncogene; 2009 Dec; 28(50):4409-20. PubMed ID: 19767776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in clinical oncoproteomics.
    Jain KK
    J BUON; 2007 Sep; 12 Suppl 1():S31-8. PubMed ID: 17935275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular targeted therapy for cancer].
    Sone S; Kuramoto T; Sato S; Mitsuhashi A; Kakiuchi S; Goto H; Tada H; Nishioka Y
    Nihon Rinsho; 2010 Jun; 68(6):997-1006. PubMed ID: 20535947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disrupting cancer cells' biocircuits with interactome-based drugs: is 'clinical' innovation realistic?
    Roukos DH
    Expert Rev Proteomics; 2012 Aug; 9(4):349-53. PubMed ID: 22967071
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular biology and cytopathology. Principles and applications.
    Schmitt FC; Vielh P
    Ann Pathol; 2012 Dec; 32(6):e57-63, 444-50. PubMed ID: 23244487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic alterations as the basis for resistance to targeted therapies.
    Blair BG; Bardelli A; Park BH
    J Pathol; 2014 Jan; 232(2):244-54. PubMed ID: 24114654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DualChip microarray as a new tool in cancer research.
    Gillet JP; de Longueville F; Remacle J
    Expert Rev Mol Diagn; 2006 May; 6(3):295-306. PubMed ID: 16706734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncoproteomics.
    Joshi S; Tiwari AK; Mondal B; Sharma A
    Clin Chim Acta; 2011 Jan; 412(3-4):217-26. PubMed ID: 20955692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic tests for molecular markers of cancer].
    Miyachi H; Asai S
    Rinsho Byori; 2003 Dec; 51(12):1195-202. PubMed ID: 14743743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenesis therapy in cancer: current challenges and future perspectives.
    Shojaei F
    Cancer Lett; 2012 Jul; 320(2):130-7. PubMed ID: 22425960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems associated with molecular targeted drugs for cancer].
    Kawaishi M; Koizum F; Nishio K
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1373-9. PubMed ID: 17033223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of and diagnostic methods for tumoral hypoxia].
    Maslennikova AV; Orlova AG; Prianikova TI; Kostenikov NA; Vinogradova IuN; Denisenko AN
    Vopr Onkol; 2011; 57(4):413-20. PubMed ID: 22191227
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell adhesion molecules: role and clinical significance in cancer.
    Makrilia N; Kollias A; Manolopoulos L; Syrigos K
    Cancer Invest; 2009 Dec; 27(10):1023-37. PubMed ID: 19909018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and cancer: current and future prospects.
    Osmak M
    Cancer Lett; 2012 Nov; 324(1):1-12. PubMed ID: 22542807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagen VI in cancer and its biological mechanisms.
    Chen P; Cescon M; Bonaldo P
    Trends Mol Med; 2013 Jul; 19(7):410-7. PubMed ID: 23639582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.